PT100156A - Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do cancro do ovario e composicoes farmaceuticas - Google Patents
Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do cancro do ovario e composicoes farmaceuticasInfo
- Publication number
- PT100156A PT100156A PT100156A PT10015692A PT100156A PT 100156 A PT100156 A PT 100156A PT 100156 A PT100156 A PT 100156A PT 10015692 A PT10015692 A PT 10015692A PT 100156 A PT100156 A PT 100156A
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- topotecan
- camptotecin
- medication
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65894891A | 1991-02-21 | 1991-02-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT100156A true PT100156A (pt) | 1993-05-31 |
| PT100156B PT100156B (pt) | 1999-09-30 |
Family
ID=24643386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT100156A PT100156B (pt) | 1991-02-21 | 1992-02-21 | Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do cancro do ovario e composicoes farmaceuticas |
Country Status (13)
| Country | Link |
|---|---|
| EP (3) | EP1690542A3 (pt) |
| JP (1) | JP2778632B2 (pt) |
| KR (1) | KR930702983A (pt) |
| AT (2) | ATE476182T1 (pt) |
| AU (1) | AU663312B2 (pt) |
| CA (1) | CA2103708C (pt) |
| DE (2) | DE69233773D1 (pt) |
| DK (2) | DK0572557T3 (pt) |
| ES (2) | ES2349037T3 (pt) |
| HK (1) | HK1012265A1 (pt) |
| MX (1) | MX9200754A (pt) |
| PT (1) | PT100156B (pt) |
| WO (1) | WO1992014469A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101255406B (zh) * | 2005-04-22 | 2010-05-26 | 李红霞 | 人卵巢癌耐药细胞株 |
| ES2371171B1 (es) * | 2010-06-08 | 2012-11-16 | Consejo Superior De Investigaciones Científicas (Csic) | Derivados de camptotecina como agentes antitumorales. |
| CN102477042A (zh) * | 2010-11-26 | 2012-05-30 | 复旦大学 | 10-羟基喜树碱衍生物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
-
1992
- 1992-02-07 ES ES05076845T patent/ES2349037T3/es not_active Expired - Lifetime
- 1992-02-07 EP EP05076846A patent/EP1690542A3/en not_active Withdrawn
- 1992-02-07 DK DK92907833.5T patent/DK0572557T3/da active
- 1992-02-07 EP EP05076845A patent/EP1707568B1/en not_active Expired - Lifetime
- 1992-02-07 AT AT05076845T patent/ATE476182T1/de active
- 1992-02-07 DE DE69233773T patent/DE69233773D1/de not_active Expired - Lifetime
- 1992-02-07 JP JP4507268A patent/JP2778632B2/ja not_active Expired - Lifetime
- 1992-02-07 DK DK05076845.6T patent/DK1707568T3/da active
- 1992-02-07 AT AT92907833T patent/ATE444755T1/de active
- 1992-02-07 AU AU14616/92A patent/AU663312B2/en not_active Expired
- 1992-02-07 WO PCT/US1992/001028 patent/WO1992014469A1/en active Application Filing
- 1992-02-07 ES ES92907833T patent/ES2334178T3/es not_active Expired - Lifetime
- 1992-02-07 KR KR1019930702490A patent/KR930702983A/ko not_active Application Discontinuation
- 1992-02-07 DE DE69233793T patent/DE69233793D1/de not_active Expired - Lifetime
- 1992-02-07 EP EP92907833A patent/EP0572557B1/en not_active Expired - Lifetime
- 1992-02-07 CA CA002103708A patent/CA2103708C/en not_active Expired - Lifetime
- 1992-02-21 PT PT100156A patent/PT100156B/pt not_active IP Right Cessation
- 1992-02-21 MX MX9200754A patent/MX9200754A/es unknown
-
1998
- 1998-12-15 HK HK98113535.8A patent/HK1012265A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE444755T1 (de) | 2009-10-15 |
| JPH06505740A (ja) | 1994-06-30 |
| CA2103708C (en) | 2004-04-27 |
| ES2349037T3 (es) | 2010-12-22 |
| DK1707568T3 (da) | 2010-11-08 |
| HK1012265A1 (en) | 1999-07-30 |
| EP1690542A2 (en) | 2006-08-16 |
| DE69233773D1 (de) | 2009-11-19 |
| KR930702983A (ko) | 1993-11-29 |
| AU663312B2 (en) | 1995-10-05 |
| DE69233793D1 (de) | 2010-09-16 |
| DK0572557T3 (da) | 2010-02-01 |
| EP1707568A2 (en) | 2006-10-04 |
| EP0572557A1 (en) | 1993-12-08 |
| EP1707568A3 (en) | 2008-03-26 |
| MX9200754A (es) | 1992-08-01 |
| CA2103708A1 (en) | 1992-08-22 |
| JP2778632B2 (ja) | 1998-07-23 |
| ATE476182T1 (de) | 2010-08-15 |
| EP1690542A3 (en) | 2008-03-26 |
| ES2334178T3 (es) | 2010-03-05 |
| AU1461692A (en) | 1992-09-15 |
| EP0572557A4 (en) | 1993-12-29 |
| PT100156B (pt) | 1999-09-30 |
| EP1707568B1 (en) | 2010-08-04 |
| WO1992014469A1 (en) | 1992-09-03 |
| EP0572557B1 (en) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69233169D1 (de) | Cisplatin und Topotecan enthaltende Zusammensetzung als antitumor. | |
| IT1276041B1 (it) | Uso del taxol per la produzione di un medicamento per il trattamento delle forme cancerose | |
| HU0301601D0 (en) | Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof | |
| IL92358A0 (en) | Diaryl compounds,their preparation and pharmaceutical compositions containing them | |
| PT100156A (pt) | Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do cancro do ovario e composicoes farmaceuticas | |
| UA41285C2 (uk) | Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність | |
| KR910018038A (ko) | 원발성 흉막암의 치료를 위한 제약 조성물 제조용 인체 인터루킨 2활성 함유 폴리펩티드의 용도 | |
| FR2701952B1 (fr) | Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| DE3665715D1 (en) | Ergoline derivatives, process for preparing them, pharmaceutical composition and use | |
| MX9401370A (es) | Terapia antiviral. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19930122 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19990622 |
|
| MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140623 |